Severe Depression
The Lancet Series on bipolar disorder
Bipolar disorder – where patients experience recurrent episodes of mood disturbance, ranging from extreme elation (mania) to severe depression – is thought to affect roughly 2% of the world's population in its most pronounced ...
Psychology & Psychiatry
May 09, 2013 |
not rated yet |
0
Nerve stimulation for severe depression changes brain function
For nearly a decade, doctors have used an implanted electronic stimulator to treat severe depression in people who don't respond to standard antidepressant therapy.
Psychology & Psychiatry
May 07, 2013 |
not rated yet |
0
|
Exercise proves to be ineffective against care home depression
Researchers at the University of Warwick and Queen Mary, University of London have shown that exercise is not effective in reducing burden of depression among elderly care home residents.
Health
May 02, 2013 |
5 / 5 (1) |
0
Antidepressants may hasten bypass recovery, study finds
(HealthDay)—Depression is relatively common in patients who undergo heart bypass surgery, and a new study finds that short-term use of antidepressants may aid patients' recovery.
Surgery
May 01, 2013 |
not rated yet |
0
Researchers look at therapeutic benefits of ketamine
The largest trial into the use of Electroconvulsive Therapy (ECT) in the UK in more than 30 years will look into how the use of the Class C drug ketamine might reduce the side effects of ECT for those being treated for severe ...
Psychology & Psychiatry
May 01, 2013 |
not rated yet |
0
ECT can restore quality of life for some severely depressed patients
Patients whose severe depression goes into remission for six months following electroconvulsive therapy report a quality of life similar to that of healthy individuals, researchers say.
Psychology & Psychiatry
Apr 15, 2013 |
not rated yet |
0
|
Study finds mothers with postpartum depression want online professional treatment
Mothers suffering from postpartum depression after a high-risk pregnancy would turn to online interventions if available anonymously and from professional healthcare providers, according to researchers from Case Western Reserve ...
Psychology & Psychiatry
Apr 04, 2013 |
not rated yet |
0
Targeting mental defeat among pain patients could prevent anxiety and depression
(Medical Xpress)—A new study of Hong Kong chronic pain patients suggests that targeting feelings of mental defeat could prevent severe depression, anxiety and interference with daily activities.
Health
Apr 03, 2013 |
not rated yet |
0
Researchers studying ketamine as suicide prevention drug
(Medical Xpress)—University of Alabama at Birmingham (UAB) researchers think ketamine, an anesthesia medication in use since the 1970s, might be a valuable tool in treating severe depression and reducing ...
Psychology & Psychiatry
Mar 27, 2013 |
5 / 5 (1) |
0
Heart failure patients with depression have four times risk of death
Heart failure patients who are moderately or severely depressed have four times the risk of dying and double the risk of having to go to the emergency room or be hospitalized compared to those who are not depressed, according ...
Cardiology
Mar 19, 2013 |
not rated yet |
0
Self help books and websites can benefit severely depressed patients
Patients with more severe depression show at least as good clinical benefit from 'low-intensity' interventions, such as self help books and websites, as less severely ill patients, suggests a paper published on BMJ websit ...
Psychology & Psychiatry
Feb 26, 2013 |
not rated yet |
0
Study finds no tie between acne drug accutane and Crohn's, colitis
(HealthDay)—A new study counters the notion that the prescription acne drug Accutane raises the risk of Crohn's disease or colitis in women.
Diseases, Conditions, Syndromes
Feb 20, 2013 |
not rated yet |
0
Could an old antidepressant treat sickle cell disease?
(Medical Xpress)—An antidepressant drug used since the 1960s may also hold promise for treating sickle cell disease, according to a surprising new finding made in mice and human red blood cells by a team ...
Medical research
Feb 19, 2013 |
5 / 5 (4) |
0
|
Are antidepressants overprescribed?
Antidepressant prescriptions in the UK have increased by 9.6% in 2011, to 46 million prescriptions. Does this reflect overmedicalisation or appropriate treatment? Two experts debate the issue on BMJ website today.
Psychology & Psychiatry
Jan 22, 2013 |
not rated yet |
0
Migraine sufferers stigmatized because of their condition: study
(HealthDay)—People who suffer from frequent migraines are stigmatized in much the same way as people with epilepsy are, new research suggests.
Diseases, Conditions, Syndromes
Jan 17, 2013 |
5 / 5 (1) |
0
Major depressive disorder (MDD) (also known as recurrent depressive disorder, clinical depression, major depression, unipolar depression, or unipolar disorder) is a mental disorder characterized by an all-encompassing low mood accompanied by low self-esteem, and by loss of interest or pleasure in normally enjoyable activities. This cluster of symptoms (syndrome) was named, described and classified as one of the mood disorders in the 1980 edition of the American Psychiatric Association's diagnostic manual. The term "depression" is ambiguous. It is often used to denote this syndrome but may refer to other mood disorders or to lower mood states lacking clinical significance. Major depressive disorder is a disabling condition that adversely affects a person's family, work or school life, sleeping and eating habits, and general health. In the United States, around 3.4% of people with major depression commit suicide, and up to 60% of people who commit suicide had depression or another mood disorder.
The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported by relatives or friends, and a mental status examination. There is no laboratory test for major depression, although physicians generally request tests for physical conditions that may cause similar symptoms. If depressive disorder is not detected in the early stages it may result in a slow recovery and affect or worsen the person's physical health. Standardized screening tools such as Major Depression Inventory can be used to detect major depressive disorder. The most common time of onset is between the ages of 20 and 30 years, with a later peak between 30 and 40 years.
Typically, patients are treated with antidepressant medication and, in many cases, also receive psychotherapy or counseling, although the effectiveness of medication for mild or moderate cases is questionable. Hospitalization may be necessary in cases with associated self-neglect or a significant risk of harm to self or others. A minority are treated with electroconvulsive therapy (ECT). The course of the disorder varies widely, from one episode lasting weeks to a lifelong disorder with recurrent major depressive episodes. Depressed individuals have shorter life expectancies than those without depression, in part because of greater susceptibility to medical illnesses and suicide. It is unclear whether or not medications affect the risk of suicide. Current and former patients may be stigmatized.
The understanding of the nature and causes of depression has evolved over the centuries, though this understanding is incomplete and has left many aspects of depression as the subject of discussion and research. Proposed causes include psychological, psycho-social, hereditary, evolutionary and biological factors. Certain types of long-term drug use can both cause and worsen depressive symptoms. Psychological treatments are based on theories of personality, interpersonal communication, and learning. Most biological theories focus on the monoamine chemicals serotonin, norepinephrine and dopamine, which are naturally present in the brain and assist communication between nerve cells.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
Consuming coffee linked to lower risk of detrimental liver disease, study finds
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
New research identifies risks, interventions for children's GI health
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
Returning genetic incidental findings without patient consent violates basic rights, experts say
Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...
Vicious cycle: Obesity sustained by changes in brain biochemistry
With obesity reaching epidemic levels in some parts of the world, scientists have only begun to understand why it is such a persistent condition. A study in the Journal of Biological Chemistry adds substantially to the st ...
White matter imaging provides insight into human and chimpanzee aging
(Medical Xpress)—The instability of "white matter" in humans may contribute to greater cognitive decline during the aging of humans compared with chimpanzees, scientists from Yerkes National Primate Research ...
Melon focus headband turns to Kickstarter for rollout plans
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
Temporal processing in the olfactory system
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
AIDS science at 30: 'Cure' now part of lexicon
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...